Effects of NUTRIOSE®FB Dietary Fiber Supplementation on Satiety, Body Fat, and Metabolic Syndrome in Overweight Adult Men

The Effects of NUTRIOSE®FB Dietary Fiber Supplementation on the Satiety, Body Fat Distribution, and Metabolic Syndrome Biomarkers of Overweight Adult Chinese Men 20-35 Years of Age.

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01044680

Enrollment

120

Registered

2010-01-08

Start date

2006-10-31

Completion date

2007-02-28

Last updated

2010-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome X, Overweight

Keywords

fiber, metabolic syndrome, overweight, satiety

Brief summary

The purpose of this study was to determine the effects of NUTRIOSE® supplementation on body composition, satiety, and determinants of metabolic syndrome in overweight men.

Detailed description

Previous trials of fiber supplementation have yielded equivocal results on body composition, satiety, and determinants of metabolic syndrome. This double-blind, randomized, placebo-controlled study was conducted to determine the effects of a proprietary soluble dextrin dietary fiber supplement (NUTRIOSE®) on these parameters in overweight males.

Interventions

DIETARY_SUPPLEMENTNUTRIOSE

17 grams of NUTRIOSE consumed twice daily for 12 weeks

DIETARY_SUPPLEMENTPlacebo

17 g maltodextrin consumed twice daily for 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

MALE

Age

20 Years to 35 Years

Healthy volunteers

Yes

Inclusion criteria

* males 20-35 years * body mass index of 24-28 kg/m2 * current employment and residence at one of three manufacturing plants with a controlled setting and with similar regimented working conditions 7 days a week

Exclusion criteria

* current or recent dietary fiber supplementation * use of lipid-lowering/hypertension medication * current insulin injection use * contraindication to fiber supplements, e.g. Crohn's disease * allergy to wheat products * recent or current antibiotic use

Design outcomes

Primary

Measure	Time frame
Determinants of metabolic syndrome	12 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026